proteasomes and its role in diseases

Embed Size (px)

Citation preview

  • 7/30/2019 proteasomes and its role in diseases

    1/22

    PROTEASOME AND ITS

    ROLE IN DISEASES

    PRESENTER: DR. SUDHESNAMODERATOR: DR ALPANA SAXENA

  • 7/30/2019 proteasomes and its role in diseases

    2/22

    DISCOVERY 1977: Alfred Goldberg

    2004: Aaron Ciechanover ,Avram Hershko ,Irwin Rose

  • 7/30/2019 proteasomes and its role in diseases

    3/22

    STRUCTURE: UPS

    UBIQUITIN :tag that marks protein for degradation

    8.5KD , 76 amino acids

    Isopeptide bond :Carboxy terminal glycine residue ofUb with amino group of lysine residue on a protein

    Requires ATP

    3 enzymes: E1-Ub activating enzyme

    E2-Ub conjugating enzyme

    E3-Ub protein ligase

  • 7/30/2019 proteasomes and its role in diseases

    4/22

  • 7/30/2019 proteasomes and its role in diseases

    5/22

    Which proteins are ubiquitinated ?

    Based on aminoterminal amino acid :

    N-terminal rule

    Cyclin destruction boxes

    PEST sequence: proline glutamic acid , serine,threonine -signal peptide for degradation

  • 7/30/2019 proteasomes and its role in diseases

    6/22

    PROTEASOME 26S proteosome 20S catalytic unit

    19S regulatory unit

  • 7/30/2019 proteasomes and its role in diseases

    7/22

    Active sites : 1) chymotrypsin like

    2) trypsin like

    3) peptidylglutamyl peptide hydrolyzing (PGPH)

  • 7/30/2019 proteasomes and its role in diseases

    8/22

    Processes regulated by protein

    degradation

    Gene transcription

    Cell cycle progression

    Circadian rhythms

    Inflammatory response

    Tumour suppression

    Antigen processing

  • 7/30/2019 proteasomes and its role in diseases

    9/22

    Role in diseases

  • 7/30/2019 proteasomes and its role in diseases

    10/22

  • 7/30/2019 proteasomes and its role in diseases

    11/22

    Decreased proteasomal activity and

    disease

    Age related decrease in proteasome activity:

    concentration of Ub-proteins

    activity of the catalytic sites

    Glycation and /or conjugation with lipid peroxidationproducts with the subunits

    PA28 proteasome activator and 19S REG

    Loss of Hsp 90 which protects 20S proteasome fromoxidative inactivation

  • 7/30/2019 proteasomes and its role in diseases

    12/22

    Cataract

    capacity to remove oxidatively damaged proteins

    26S proteasome is itself sensitive to oxidativeinactivation

  • 7/30/2019 proteasomes and its role in diseases

    13/22

    Neurodegenerative diseases

    20S proteasome activity ( substantia nigra , striatum ,cerebral cortex, spinal cord)

    Accumulation of abnormal proteins

    Development of neurodegenerative diseases (PD, AD,HD, ALS)

    Protein inclusions/misfolded oligomers furtherinhibit proteasome activity

  • 7/30/2019 proteasomes and its role in diseases

    14/22

    Parkinsons disease

    Mutations in parkin gene

    Parkin is a Ub-protein ligase

    Parkin-associated endothelial like (Pael) receptor isoverexpressed in PD , parkin ubiquitinates it and promotes

    its degradation

    Mutations of ubiquitin carboxyterminal hydrolase (Decrease Ub recycling)

    Proteasome inhibitor causes PD like syndrome

    Knocking out PSMC1 gene that codes a subunit of 19Sproteasome causes Lewy body like inclusions.

  • 7/30/2019 proteasomes and its role in diseases

    15/22

    Enhanced proteasome activity in

    diseases

    Muscle atrophy (CKD , Type 1 DM , sepsis ,cachexia andstarvation) :

    protein synthesis and protein degradation

    Enhanced transcription of genes encoding proteasomesubunits

    mRNA levels of 19S regulator subunit

    Proteasome inhibitors like lactacystin , PSIprevented sepsis induced protein degradation

    Role of NF

  • 7/30/2019 proteasomes and its role in diseases

    16/22

    Cancer

    Both antiapoptotic and proapoptotic effects

    Proteasomes degrade pro-apototic proteins Bax,Bid,p53,bcl-2 and cell cycle regulators pRb, cyclin D,p27

    Proteasomes are involved in DNA damage signallingprocesses like IR-induced foci formation ofphosphorylated ATM , 53BPI,BS1, BRCA1, FANCD2,RAD 51

    These pathways were inhibited by proteasomeinhibitors

    Sensitization of tumor cells to chemotherapeuticagents

  • 7/30/2019 proteasomes and its role in diseases

    17/22

    Multiple myeloma

    NFtranscription activator Causes proliferation of multiple myeloma cells

    Increased levels of proteasome and mRNA (enzymaticimmunoassay and northern blot analysis )

    Bortezomib :

  • 7/30/2019 proteasomes and its role in diseases

    18/22

    Multiple myeloma

  • 7/30/2019 proteasomes and its role in diseases

    19/22

    Role in immune system

    Immunoproteasome :

    Peptide Ag displayed by the MHC class 1on APC are products

    of proteasomal degradation of proteins of pathogens.

    specialized complex induced by IFN-.

    Composed of1i, 2i, 5i and 11S regulatory particle

    Cervical carcinoma and melanoma: defective 5i Cytotoxic

    immune response suppression

    HIV : suppression of synthesis of2i

  • 7/30/2019 proteasomes and its role in diseases

    20/22

    Acute GVHD:

    Systemic protease inhibition by Bortezomib leadsto :

    apoptosis of alloreactive T lymphocytes

    inhibition of NF

    Autoimmune disorders :

    Proteosome inhibition inhibition of NF

    decreases iNOS

    In trials for Rheumatoid arthritis and Multiple

    sclerosis

  • 7/30/2019 proteasomes and its role in diseases

    21/22

    Drugs: PS-341

    Bortezomib (Velcade)

    Salinosporin/Salinosporamide

    Indications:

    Multiple myeloma

    Mantle cell lymphoma

    Solid Organ transplantations

    Rheumatoid arthritis

    Multiple sclerosis

  • 7/30/2019 proteasomes and its role in diseases

    22/22

    Thank you